Exact Sciences Plans to Net $56.2M in Public Offering

Uses of the proceeds include funding clinical trials and obtaining FDA clearance for its sDNA colorectal cancer screening test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories